Randomized controlled clinical trial of minimally invasive breast surgery with contrast-enhanced ultrasound in pathological nipple discharge

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100045025

Enrollment

Unknown

Registered

2021-04-03

Start date

2021-04-05

Completion date

Unknown

Last updated

2021-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast nipple discharge

Interventions

Minimally invasive surgery group:Minimally invasive surgery

Open surgery group:Open surgery

Eligibility

Sex/Gender

Female

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Female patients aged between 18 and 75; 2.Patients with pathological nipple discharge requiring surgical intervention; 3.Participants are required to participate in this clinical trial voluntarily and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1.Pregnant women; 2.Breast cancer patients with pathologically confirmed; 3.Patients participated in clinical trials of other devices or drugs within one month; 4.Patients who cannot tolerate surgery or voluntarily give up surgical treatment due to dysfunction of heart, brain, lung and other important organs; 5.Patients deemed unsuitable for this clinical trial by the investigator.

Design outcomes

Primary

Measure	Time frame
The difference of postoperative scar length of surgical incision;The difference of postoperative cosmetic effect and patient satisfaction;	—

Countries

China

Contacts

Public ContactGao Yinguang

Beijing Friendship Hospital, Capital Medical University

gaoyinguang@163.com+86 13691099801

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026